Dessert, V.; Maurer, S.M.; Maurer, M.S.; Albrecht, D.; Farshad, M.; Uçkay, İ.
Evaluating the Link Between Postoperative Timing of Rifampicin Introduction and the Clinical and Microbiological Outcomes of Orthopedic Staphylococcal Implant Infections. Antibiotics 2025, 14, 1043.
https://doi.org/10.3390/antibiotics14101043
AMA Style
Dessert V, Maurer SM, Maurer MS, Albrecht D, Farshad M, Uçkay İ.
Evaluating the Link Between Postoperative Timing of Rifampicin Introduction and the Clinical and Microbiological Outcomes of Orthopedic Staphylococcal Implant Infections. Antibiotics. 2025; 14(10):1043.
https://doi.org/10.3390/antibiotics14101043
Chicago/Turabian Style
Dessert, Valeria, Steven M. Maurer, Marc S. Maurer, David Albrecht, Mazda Farshad, and İlker Uçkay.
2025. "Evaluating the Link Between Postoperative Timing of Rifampicin Introduction and the Clinical and Microbiological Outcomes of Orthopedic Staphylococcal Implant Infections" Antibiotics 14, no. 10: 1043.
https://doi.org/10.3390/antibiotics14101043
APA Style
Dessert, V., Maurer, S. M., Maurer, M. S., Albrecht, D., Farshad, M., & Uçkay, İ.
(2025). Evaluating the Link Between Postoperative Timing of Rifampicin Introduction and the Clinical and Microbiological Outcomes of Orthopedic Staphylococcal Implant Infections. Antibiotics, 14(10), 1043.
https://doi.org/10.3390/antibiotics14101043
